Skip to search formSkip to main contentSkip to account menu

progabide

Known as: Butanamide, 4-(((4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methylene)amino)-, Progabida, Progabidum 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Summary: Twenty therapy‐resistant epileptic patients entered a double‐blind, randomized, two‐period, crossover trial comparing… 
1983
1983
Summary: In this double‐blind, two‐period, crossover trial with randomized treatment assignment, progabide (±30 mg/kg/day) and…